Value-based price for access (VBPA) may increase access of specialty drugs for patients.
Scott Howell
Advertisement
Former chief strategy officer, Novartis Pharmaceuticals Corporation
Articles by Scott Howell
Advertisement
Latest Updated Articles
Advertisement
Advertisement